中国组织工程研究 ›› 2016, Vol. 20 ›› Issue (31): 4596-4602.doi: 10.3969/j.issn.2095-4344.2016.31.005

• 人工假体 artificial prosthesis • 上一篇    下一篇

乙型血友病性肩关节炎肱骨头坏死置换治疗1例

祁伟仲,林荔军,李 奇   

  1. 南方医科大学珠江医院骨科中心,广东省广州市 510282
  • 修回日期:2016-05-10 出版日期:2016-07-22 发布日期:2016-07-22
  • 通讯作者: 李奇,博士,博士生导师,教授,主任医师,南方医科大学珠江医院骨科中心,广东省广州市 510282
  • 作者简介:祁伟仲,男,1990年生,江苏省阜宁县人,汉族,2016年南方医科大学毕业,硕士,医师,主要从事关节外科临床工作。

Humeral head replacement in a hemophilia B omarthritis patient

Qi Wei-zhong, Lin Li-jun, Li Qi   

  1. Orthopedics Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China
  • Revised:2016-05-10 Online:2016-07-22 Published:2016-07-22
  • Contact: Li Qi, M.D., Doctoral supervisor, Professor, Chief physician, Orthopedics Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China
  • About author:Qi Wei-zhong, Master, Physician, Orthopedics Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China

摘要:

文章快速阅读:

文题释义:
乙型血友病:乙型血友病是一种以Ⅸ因子缺乏为主要特征的X连锁隐性遗传性出血性疾病。诊断主要依靠出血发作病史及凝血功能实验,基因突变筛查及DNA测序等方式可确诊。而创伤性检查易引起再度出血,所以应避免活检。
乙型血友病性关节炎:是血友病患者关节致畸主要原因之一。患者早期即可出现关节内出血,初发症状较轻休息后可缓解吸收;而反复出血会导致含铁血黄素的沉积,累及的铁血黄素沉着于滑膜后的代谢产物又进一步诱导软骨细胞凋亡。由于关节内滑膜纤维性增厚及炎症作用再加上局部透明软骨分解,最终导致继发骨性关节炎并遗留屈曲挛缩畸形。因此,手术切除受累关节周围增生及变性的组织,是减轻术后疼痛及改善关节功能的重要条件。
 
摘要
背景:过去对乙型血友病性关节炎的手术治疗多面临手术难度大、术中出血难以估计、创面愈合困难等情况。而在围手术期间将患者凝血Ⅸ因子活性控制在安全范围时,可保证手术的安全进行,创面愈合好,康复情况佳,远期未见明显并发症。
目的:探讨乙型血友病性肩关节炎行肱骨头置换的围手术期诊治要点,分析对预后及康复的重要性。
方法:通过文献复习,总结乙型血友病性关节炎行外科治疗的意义及围手术期并发症的防治处理。对1例乙型血友病性肩关节炎诊断后,在监控凝血因子活性,输注人凝血酶原复合物及冰冻血浆的条件下行肱骨头置换治疗。
结果与结论:①通过监控治疗,患者在凝血Ⅸ因子活性由7%上升到50%的情况下接受肱骨头置换手术;②置换后3 d内将凝血Ⅸ因子控制在> 30%,3 d至2周内控制在>20%时,术后未见明显并发症;③结果提示,乙型血友病性关节炎行外科治疗较常见,对其病情评估及处理十分重要。肱骨头置换围手术期采用人凝血酶原复合物替代治疗,将凝血因子活性控制于适宜范围,可有效预防患者置换后并发症的发生。

中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱骨折;内固定;数字化骨科;组织工程

ORCID:
0000-0001-5409-0249(李奇)

关键词: 骨科植入物, 人工假体, 肱骨头置换, 乙型血友病, 肩关节炎, 替代治疗, 人凝血酶原复合物

Abstract:

BACKGROUND: In the past, the surgical treatment of patients with hemophilia B was difficult, the bleeding was difficult to estimate, and the wound healing was difficult. In the perioperative period, the control of coagulation factor IX activity in a safe range can ensure the safety of the operation, resulting in well wound healing, good recovery, and no significant complications appeared in the long term.

OBJECTIVE: To study essentials of perioperative diagnosis and treatment in omarthritis patients with hemophilia B undergoing humeral head replacement, and to analyze the importance on prognosis and rehabilitation.
METHODS: The significance of surgical treatment for hemophilia B patients with arthritis, the prevention and treatment of perioperative complications were summarized through literature review. Humeral head replacement was conducted in a patient with hemophilia omarthritis by monitoring coagulation factor activity and infusing human prothrombin complex and frozen plasma. 
RESULTS AND CONCLUSION: (1) According to the monitoring, patients, whose coagulation factor IX activity increased from 7% to 50%, underwent humeral head replacement. (2) Within three days after replacement, coagulation factor IX activity was controlled > 30%, 3 days-2 weeks > 20%. No obvious complication was found after surgery. (3) These results suggested that hemophilia B arthritis was commonly treated by surgical treatment, which plays an important role in assessing patient’s condition and treatment. During perioperative period, replacement therapy of human prothrombin complex and control of coagulation factor activity in a appropriate range can effectively prevent postoperative complications. 

中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱骨折;内固定;数字化骨科;组织工程

Key words: Arthroplasty, Replacement, Prosthesis Implantation, Shoulder Joint, Arthritis, Tissue Engineering

中图分类号: